U.S. Hospitality Stock News

NYSE:SPGI
NYSE:SPGICapital Markets

Is It Time To Reassess S&P Global (SPGI) After Recent Share Price Weakness?

Wondering whether S&P Global at around US$439 a share still makes sense for your portfolio, or if the value case has shifted. The stock has moved 0.5% over the past week and 6.8% over the last 30 days, while the year to date return sits at a 14.4% decline and the 1 year return at an 8.1% decline, against a 26.5% and 16.5% gain over 3 and 5 years respectively. These mixed returns come against a backdrop of ongoing attention on index providers, credit ratings, and financial data groups, with...
NasdaqGM:FOLD
NasdaqGM:FOLDBiotechs

Assessing Amicus Therapeutics (FOLD) Valuation After Recent Share Price Momentum And Rare Disease Growth Prospects

Why Amicus Therapeutics is on investors’ radar today Amicus Therapeutics (FOLD) has caught investor attention after recent performance data showed modest positive returns over the past month and past 3 months, prompting closer focus on how its rare disease portfolio supports the current valuation. See our latest analysis for Amicus Therapeutics. At a share price of $14.46, Amicus Therapeutics shows only modest short term share price returns. The 1 year total shareholder return of 100.83%...
NasdaqGS:EBAY
NasdaqGS:EBAYMultiline Retail

eBay Tightens Focus On Resale As San Francisco Office Closes

eBay (NasdaqGS:EBAY) is closing its San Francisco office, reflecting a shift in how the company uses physical workspaces. The company is also reducing staff, aligning its workforce with a tighter focus on peer to peer and resale activity. These changes follow eBay's acquisition of U.K. resale platform Depop, underscoring a push into apparel and recommerce. For you as an investor, these moves highlight how eBay is concentrating on its core marketplace role, especially in consumer to consumer...
NasdaqGS:CLBT
NasdaqGS:CLBTSoftware

Reassessing Cellebrite DI (NasdaqGS:CLBT) Valuation After Recent Share Price Weakness

Why Cellebrite DI (NasdaqGS:CLBT) is drawing fresh attention Cellebrite DI (NasdaqGS:CLBT) is back on investors’ radar after a period of mixed share performance, with recent moves contrasting sharply with its stronger multi year total return record and raising questions about the current valuation. See our latest analysis for Cellebrite DI. The recent share price of $12.73 comes after a 1 day share price decline of 4.29% and a 30 day share price decline of 10.42%. The 3 year total shareholder...
NYSE:PRGO
NYSE:PRGOPharmaceuticals

Assessing Perrigo (PRGO) Valuation After Recent Share Price Volatility

Context for Perrigo after recent performance Perrigo (PRGO) has caught investor attention after recent share price moves, with the stock up about 21% over the past month but showing a decline of roughly 21% in the past 3 months. See our latest analysis for Perrigo. While the recent 1 month share price return of 21.3% hints at improving sentiment, the 1 year total shareholder return of 49.8% and 5 year total shareholder return of 66.2% indicate that long term performance has been weak and...
NYSE:CHH
NYSE:CHHHospitality

Has The Easy Money Been Made In Choice Hotels International (CHH) After Recent Rally?

Wondering if Choice Hotels International at around US$120 is offering good value today or if the easy money has already been made? This article walks through what the current price might actually be saying. The stock has recently shown mixed performance, with a 1.7% return over the last 7 days, 21.2% over 30 days and 24.9% year to date, set against a 3.9% decline over the past year and a 9.2% return over five years. Recent coverage has focused on how Choice Hotels International fits into the...
NasdaqGS:TW
NasdaqGS:TWCapital Markets

Assessing Tradeweb Markets (TW) Valuation After Mixed Short And Long Term Share Returns

How Tradeweb Markets Stock Is Positioned After Recent Returns Tradeweb Markets (TW) has caught investor attention after a recent mix of shorter term weakness and longer term strength, with the stock showing a 7% decline over the past month but a gain over the past 3 months. This pattern, combined with its latest closing price of US$113.62 and current valuation metrics, is prompting closer scrutiny of how the electronic marketplaces operator is balancing growth, profitability and price. See...
NYSE:CF
NYSE:CFChemicals

Is It Too Late To Consider CF Industries (CF) After Strong 66% One Year Rally?

If you are wondering whether CF Industries Holdings at around US$125.59 is priced for more gains or already reflecting the story, a useful starting point is to understand what the current market value implies. The stock has recently shown a 0.7% return over the last 7 days, a 1.0% decline over 30 days, and much stronger returns of 56.7% year to date and 66.2% over the last year, which can affect how much upside or downside investors feel is left. Recent news has focused on CF Industries...
NasdaqGS:MCHP
NasdaqGS:MCHPSemiconductor

Microchip And Intel Target AI Data Centers As Valuation Runs Hot

Microchip Technology introduced its MD-990-0011-B timing module family for data centers and 5G vRAN. The plug in modules are designed to support high precision synchronization for AI focused cloud and networking workloads. The products were developed in collaboration with Intel, targeting AI infrastructure in server and networking ecosystems. For investors watching Microchip Technology (NasdaqGS:MCHP), this product launch comes with the stock trading at $90.64. The share price sits...
NYSE:UNM
NYSE:UNMInsurance

Is It Time To Reconsider Unum Group (UNM) After A 215% Five Year Share Price Surge

If you are wondering whether Unum Group's share price still offers value, the recent performance gives you a lot to think about. The stock last closed at US$77.76, with a 1.5% decline over 7 days, a 5.3% gain over 30 days, a 0.7% return year to date, a 0.9% return over 1 year, 103.9% over 3 years and a very large 214.7% over 5 years. Recent coverage has focused on Unum Group as a US insurance name that investors watch for its mix of protection products and group benefits. This often draws...
NasdaqGS:ZG
NasdaqGS:ZGReal Estate

Assessing Zillow Group (ZG) Valuation After Recent Share Price Weakness

Recent share performance and what it might signal Zillow Group (ZG) has seen its share price under pressure recently, with a 34% decline over the past 3 months and a 32% drop year to date, bringing the latest close to $44.50. Over the past year, the total return stands at a 31% decline, while the 3 year total return is 7% and the 5 year total return reflects a 67% decline, giving investors a mixed picture of longer term performance. These moves come as Zillow Group reports annual revenue of...
NasdaqGM:USAR
NasdaqGM:USARMetals and Mining

Has USA Rare Earth (USAR) Risen Too Far After Recent Critical Minerals Spotlight?

Investors may be wondering whether USA Rare Earth's current share price reflects its fundamental worth, or if recent excitement has pushed it ahead of the underlying value story. The stock last closed at US$23.09, with returns of 25.3% over 7 days, 39.1% over 30 days, 63.2% year to date and 74.5% over 1 year. This naturally raises questions about how much of the valuation case is already reflected in the price. Recent coverage of USA Rare Earth's role in supplying materials that are...
NYSE:EPRT
NYSE:EPRTREITs

FFO Growth At Essential Properties Realty Trust (EPRT) Tests Long Lease Stability Narrative

Essential Properties Realty Trust (EPRT) has kicked off Q1 2026 with total revenue of US$158.8 million, basic EPS of US$0.28 and net income of US$59.8 million, with management and investors also watching FFO of US$114.6 million and FFO per share of US$0.54 as key REIT metrics. Over the past year, the company has seen revenue move from US$129.4 million and basic EPS of US$0.30 in Q1 2025 to US$158.8 million and US$0.28 in the latest quarter, while trailing twelve month revenue reached US$590.7...
NasdaqGM:IRON
NasdaqGM:IRONBiotechs

Will Insider 10b5-1 Sales and New ASCO Data Shift Disc Medicine's (IRON) Narrative?

Disc Medicine recently reported that its Chief Medical Officer, William Jacob Savage, sold 5,731 shares under a pre-arranged 10b5-1 trading plan while its lead program, bitopertin, continues in the Phase 3 APOLLO study with topline data expected later this year. Separately, the company said it will present new Phase 2 RALLY-MF trial data for DISC-0974 in anemia of myelofibrosis at the upcoming ASCO Annual Meeting, building on earlier results that showed unusually strong anemia response rates...
NasdaqGS:XP
NasdaqGS:XPCapital Markets

Is XP (NasdaqGS:XP) Still Offering Value After Mixed Recent Share Price Moves

If you are wondering whether XP at around US$19.63 is still offering value or already pricing in the story, you are not alone. The stock has seen mixed moves recently, with a 7.1% decline over the past week, a 2.1% gain over 30 days, and returns of 21.3% year to date and 27.4% over the last year that may be reshaping how investors think about its risk and reward. Recent news coverage around XP has largely focused on its role in Brazil's capital markets and its position in the broader...
NasdaqGM:CRSP
NasdaqGM:CRSPBiotechs

Is CRISPR Therapeutics (CRSP) Share Price Aligning With Its Long Term Growth Story?

Wondering whether CRISPR Therapeutics at US$55.18 is priced for its potential or already demanding a premium? This article focuses squarely on what the current market value might be telling you. The stock has seen a 41.1% return over the last year, with a 30 day return of 18.8%, while also showing shorter term volatility such as a 1% decline over the last week and a 5 year return of negative 58.2%. Recent headlines around CRISPR Therapeutics continue to keep attention on the company,...
NYSE:TYL
NYSE:TYLSoftware

Did Lake County’s Mobile Rollout Just Shift Tyler Technologies’ (TYL) Government Cloud Adoption Narrative?

Tyler Technologies, Inc. recently announced that the Lake County Sheriff’s Office in Illinois has gone live with its Enterprise Public Safety suite, including Enforcement Mobile, Civil Serve, and Corrections Mobile, giving officers real-time access to digital records and reducing manual data entry. This rollout shows how Tyler’s mobile and cloud-based tools can materially reshape daily workflows for a large public safety agency serving more than 720,000 residents. Next, we’ll examine how...
NYSE:RYAN
NYSE:RYANInsurance

Is Ryan Specialty Holdings (RYAN) Pricing Look Interesting After Recent Share Price Weakness?

Wondering whether Ryan Specialty Holdings at US$35.40 is starting to look interesting on price, or if the recent weakness is a warning sign? This article breaks down what the current valuation is actually telling you. The stock has seen a 5.3% decline over the last 7 days, a 5.6% gain over the last 30 days, and returns of 30.1% decline year to date and 48.7% decline over the last year. This raises questions about how sentiment and risk are shifting around the name. Recent coverage has...
NYSE:FAF
NYSE:FAFInsurance

First American Financial (FAF) Margin Rebound Tests Bullish Profitability Narratives Ahead Of Q1 2026

First American Financial (FAF) has followed up its earnings rebound with trailing 12‑month revenue of about US$7.5 billion and basic EPS of US$6.02, alongside year‑over‑year reported earnings growth of very roughly 4x and a net profit margin of 8.3% versus 2.1% a year earlier. The company has seen quarterly revenue move from US$1,406.1 million in Q3 2024 to US$1,685.1 million in Q4 2024 and then to US$2,049.7 million in Q4 2025, with basic EPS shifting from a loss of US$1.00 in Q3 2024 to...
NYSE:LHX
NYSE:LHXAerospace & Defense

L3Harris Missile Unit Draws US$1b Investment And Potential IPO Rerating

L3Harris Technologies (NYSE:LHX) received a $1b investment from the Department of War into its Missile Solutions business. The funding is structured as a convertible preferred security that is set to convert to equity at a planned IPO of the Missile Solutions unit. Capital is earmarked for facility expansion, R&D, and national security production within the missile segment. L3Harris is a major defense contractor with a focus on communications, mission systems, and missile related...
NYSE:MKL
NYSE:MKLInsurance

Is Markel Group (MKL) Pricing Reflect Its Mixed Returns And Intrinsic Value Estimates

Wondering if Markel Group at around US$1,929.91 is offering fair value or a potential mispricing opportunity? This article walks through the key numbers so you can judge for yourself. The stock has seen mixed returns, with a 1.9% decline over the last 7 days, a 1.7% gain over 30 days, and a 6.7% return over 1 year. The longer 3 year and 5 year returns sit at 45.8% and 64.4% respectively. These moves sit against a backdrop of ongoing attention on Markel Group as an insurance and investment...
NasdaqGS:AMSC
NasdaqGS:AMSCElectrical

Is It Too Late To Consider American Superconductor (AMSC) After A 129% One-Year Surge?

Wondering if American Superconductor at around US$46.15 is still offering value or if the easy money has already been made? This article breaks down what the current price might really imply. The stock has seen sharp moves recently, with returns of 21.5% over 7 days, 43.3% over 30 days, 46.1% year to date and 129.3% over 1 year, along with a very large 3 year return that sits above 7x. These moves come as American Superconductor continues to attract attention from investors looking at power...
NasdaqGS:TROW
NasdaqGS:TROWCapital Markets

Assessing T. Rowe Price (TROW) Valuation After Expanded 55ip Tax Optimization Partnership

Fresh attention is turning to T. Rowe Price Group (TROW) after 55ip, a J.P. Morgan subsidiary, expanded its collaboration with the asset manager to deliver tax-focused custom model portfolios for financial advisors. See our latest analysis for T. Rowe Price Group. The dual-share class approval and the expanded 55ip partnership come as T. Rowe Price Group’s share price sits at US$99.49, with a 12.04% 1 month share price return but a 5 year total shareholder return of negative 31.28%. This...